API Synthesis and Manufacturing, Large Molecule

May 16, 2018
By BioPharm International Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
Apr 20, 2018
By BioPharm International Editors
The new platform is expected to speed up cell line development.
Apr 17, 2018
By BioPharm International Editors
Industry experts will discuss lyophilization best practices and continuous manufacturing for biopharmaceuticals.
Apr 16, 2018
By BioPharm International Editors
Kemiex trading network is designed to increase safety in the sourcing of APIs and additives.
Apr 16, 2018
By BioPharm International Editors
A new report gives an overview of the work of the International API Inspection Program.
Apr 10, 2018
By BioPharm International Editors
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
Apr 05, 2018
By BioPharm International Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Mar 29, 2018
By BioPharm International Editors
The companies will co-develop and co-promote a CAR T cell therapy in the United States.
Mar 23, 2018
By BioPharm International Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
native1_300x100
lorem ipsum